Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Benefit of Apabetalone on Plasma Proteins in Renal Disease.
Journal: Kidney international reports
Published: October 18, 2017
Downregulation of the Complement Cascade In Vitro, in Mice and in Patients with Cardiovascular Disease by the BET Protein Inhibitor Apabetalone (RVX-208).
Journal: Journal of cardiovascular translational research
Published: December 21, 2016
Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes.
Journal: Data in brief
Published: January 28, 2016
An evaluation of RVX-208 for the treatment of atherosclerosis.
Journal: Expert opinion on investigational drugs
Published: September 15, 2015
Showing 1-4 of 4
Last Updated: 09/26/2026